[HTML][HTML] B-and T-cell immune responses elicited by the Comirnaty® COVID-19 vaccine in nursing-home residents
I Torres, E Albert, E Giménez, MJ Alcaraz… - Clinical Microbiology …, 2021 - Elsevier
Objectives The immunogenicity of the Comirnaty® vaccine against coronavirus disease
2019 (COVID-19) has not been adequately studied in elderly people with comorbidities. We …
2019 (COVID-19) has not been adequately studied in elderly people with comorbidities. We …
Kinetics of COVID-19 mRNA primary and booster vaccine-associated neutralizing activity against SARS-CoV-2 variants of concern in long-term care facility residents …
T Kakugawa, K Doi, Y Ohteru, H Kakugawa, K Oishi… - Immunity & …, 2023 - Springer
Abstract Background Coronavirus disease 2019 (COVID-19) remains a threat to vulnerable
populations such as long-term care facility (LTCF) residents, who are often older, severely …
populations such as long-term care facility (LTCF) residents, who are often older, severely …
Antibody responses after mRNA-based COVID-19 vaccination in residential older adults: implications for reopening
DA Nace, KE Kip, JW Mellors, OMP Palmer… - Journal of the American …, 2021 - Elsevier
Objective COVID-19 disproportionately impacts residents in long-term care facilities. Our
objective was to quantify the presence and magnitude of antibody response in vaccinated …
objective was to quantify the presence and magnitude of antibody response in vaccinated …
[HTML][HTML] COVID-19 vaccination and frailty in older adults
LK Chen - Archives of gerontology and geriatrics, 2021 - ncbi.nlm.nih.gov
The COVID-19 pandemic strongly impacts the whole world in various dimensions (Wang,
2020), and studies have shown the high mortality risk of older patients with COVID-19 …
2020), and studies have shown the high mortality risk of older patients with COVID-19 …
Reduced magnitude and durability of humoral immune responses to COVID-19 mRNA vaccines among older adults
MA Brockman, F Mwimanzi, HR Lapointe… - The Journal of …, 2022 - academic.oup.com
Background The magnitude and durability of immune responses to coronavirus disease
2019 (COVID-19) mRNA vaccines remain incompletely characterized in the elderly …
2019 (COVID-19) mRNA vaccines remain incompletely characterized in the elderly …
Humoral immunity induced by mRNA COVID-19 vaccines in nursing home residents previously infected with SARS-CoV-2
G Fedele, A Palmieri, C Damiano, A Di Lonardo… - Aging Clinical and …, 2022 - Springer
Background Nursing home (NH) residents suffered the greatest impact of the COVID-19
pandemic. Limited data are available on vaccine-induced immunity and on the protection …
pandemic. Limited data are available on vaccine-induced immunity and on the protection …
[HTML][HTML] Functional immunity against SARS-CoV-2 in the general population after a booster campaign and the Delta and Omicron waves, Switzerland, March 2022
Functional immunity (defined here as serum neutralising capacity) critically contributes to
conferring protection against SARS-CoV-2 infection and severe COVID-19. This cross …
conferring protection against SARS-CoV-2 infection and severe COVID-19. This cross …
Trajectories of seroprevalence and neutralizing activity of antibodies against SARS-CoV-2 in Southern Switzerland between July 2020 and July 2021: an ongoing …
R Amati, G Piumatti, G Franscella, P Buttaroni… - International Journal of …, 2023 - mdpi.com
Objectives: The COVID-19 pandemic continues, and evidence on infection-and vaccine-
induced immunity is key. We assessed COVID-19 immunity and the neutralizing antibody …
induced immunity is key. We assessed COVID-19 immunity and the neutralizing antibody …
Antibody and cellular immune responses following dual COVID-19 vaccination within infection-naive residents of long-term care facilities: an observational cohort …
G Tut, T Lancaster, P Sylla, MS Butler… - The Lancet Healthy …, 2022 - thelancet.com
Background Older age and frailty are risk factors for poor clinical outcomes following SARS-
CoV-2 infection. As such, COVID-19 vaccination has been prioritised for individuals with …
CoV-2 infection. As such, COVID-19 vaccination has been prioritised for individuals with …
[HTML][HTML] Outbreak of SARS-CoV-2 B. 1.617. 2 (delta) variant in a nursing home 28 weeks after two doses of mRNA anti-COVID-19 vaccines: evidence of a waning …
A Pierobon, A Dal Zotto, A Antico, ME De Antoni… - Clinical Microbiology …, 2022 - Elsevier
Objectives To describe a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) B.
1.617. 2 (Delta) variant outbreak among residents (n= 69) and health workers (n= 69) of a …
1.617. 2 (Delta) variant outbreak among residents (n= 69) and health workers (n= 69) of a …